nodes	percent_of_prediction	percent_of_DWPC	metapath
Verteporfin—Eczema—Bupropion—obesity	0.00384	0.00384	CcSEcCtD
Verteporfin—Headache—Methamphetamine—obesity	0.00383	0.00383	CcSEcCtD
Verteporfin—Arthralgia—Cimetidine—obesity	0.0038	0.0038	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Phentermine—obesity	0.00379	0.00379	CcSEcCtD
Verteporfin—Feeling abnormal—Phenylpropanolamine—obesity	0.00378	0.00378	CcSEcCtD
Verteporfin—Constipation—Phentermine—obesity	0.00376	0.00376	CcSEcCtD
Verteporfin—Blood creatinine increased—Sibutramine—obesity	0.00371	0.00371	CcSEcCtD
Verteporfin—Hyperhidrosis—Diethylpropion—obesity	0.0037	0.0037	CcSEcCtD
Verteporfin—Headache—Benzphetamine—obesity	0.0037	0.0037	CcSEcCtD
Verteporfin—Liver function test abnormal—Sibutramine—obesity	0.00365	0.00365	CcSEcCtD
Verteporfin—Visual disturbance—Bupropion—obesity	0.00364	0.00364	CcSEcCtD
Verteporfin—Dizziness—Phendimetrazine—obesity	0.00356	0.00356	CcSEcCtD
Verteporfin—Influenza—Orlistat—obesity	0.00353	0.00353	CcSEcCtD
Verteporfin—Nausea—Benzphetamine—obesity	0.0035	0.0035	CcSEcCtD
Verteporfin—Urticaria—Phentermine—obesity	0.00349	0.00349	CcSEcCtD
Verteporfin—Muscular weakness—Sibutramine—obesity	0.00349	0.00349	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Diethylpropion—obesity	0.00348	0.00348	CcSEcCtD
Verteporfin—Osteoarthritis—Bupropion—obesity	0.00345	0.00345	CcSEcCtD
Verteporfin—Diplopia—Bupropion—obesity	0.00345	0.00345	CcSEcCtD
Verteporfin—Influenza—Sibutramine—obesity	0.00342	0.00342	CcSEcCtD
Verteporfin—Dyspnoea—Diethylpropion—obesity	0.00341	0.00341	CcSEcCtD
Verteporfin—Hypersensitivity—Phenylpropanolamine—obesity	0.00338	0.00338	CcSEcCtD
Verteporfin—Headache—Phendimetrazine—obesity	0.00337	0.00337	CcSEcCtD
Verteporfin—Arthropathy—Topiramate—obesity	0.00333	0.00333	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Cimetidine—obesity	0.00331	0.00331	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Diethylpropion—obesity	0.0033	0.0033	CcSEcCtD
Verteporfin—Constipation—Diethylpropion—obesity	0.00327	0.00327	CcSEcCtD
Verteporfin—Nausea—Phendimetrazine—obesity	0.00319	0.00319	CcSEcCtD
Verteporfin—Hearing impaired—Topiramate—obesity	0.00318	0.00318	CcSEcCtD
Verteporfin—Creatinine increased—Topiramate—obesity	0.00318	0.00318	CcSEcCtD
Verteporfin—Asthenia—Phentermine—obesity	0.00315	0.00315	CcSEcCtD
Verteporfin—Feeling abnormal—Diethylpropion—obesity	0.00315	0.00315	CcSEcCtD
Verteporfin—Photosensitivity reaction—Sibutramine—obesity	0.00312	0.00312	CcSEcCtD
Verteporfin—Constipation—Cimetidine—obesity	0.00311	0.00311	CcSEcCtD
Verteporfin—Pneumonia—Sibutramine—obesity	0.00307	0.00307	CcSEcCtD
Verteporfin—Musculoskeletal pain—Topiramate—obesity	0.00306	0.00306	CcSEcCtD
Verteporfin—Muscular weakness—Bupropion—obesity	0.00304	0.00304	CcSEcCtD
Verteporfin—Urticaria—Diethylpropion—obesity	0.00304	0.00304	CcSEcCtD
Verteporfin—Dizziness—Phenylpropanolamine—obesity	0.00304	0.00304	CcSEcCtD
Verteporfin—Acute coronary syndrome—Sibutramine—obesity	0.003	0.003	CcSEcCtD
Verteporfin—Feeling abnormal—Cimetidine—obesity	0.003	0.003	CcSEcCtD
Verteporfin—Myocardial infarction—Sibutramine—obesity	0.00299	0.00299	CcSEcCtD
Verteporfin—Influenza—Bupropion—obesity	0.00298	0.00298	CcSEcCtD
Verteporfin—Conjunctivitis—Sibutramine—obesity	0.00296	0.00296	CcSEcCtD
Verteporfin—Sweating—Sibutramine—obesity	0.00292	0.00292	CcSEcCtD
Verteporfin—Dizziness—Phentermine—obesity	0.00291	0.00291	CcSEcCtD
Verteporfin—Rash—Phenylpropanolamine—obesity	0.0029	0.0029	CcSEcCtD
Verteporfin—Dermatitis—Phenylpropanolamine—obesity	0.00289	0.00289	CcSEcCtD
Verteporfin—Body temperature increased—Cimetidine—obesity	0.00288	0.00288	CcSEcCtD
Verteporfin—Haemoglobin—Orlistat—obesity	0.00284	0.00284	CcSEcCtD
Verteporfin—Haemorrhage—Orlistat—obesity	0.00283	0.00283	CcSEcCtD
Verteporfin—Pharyngitis—Orlistat—obesity	0.00281	0.00281	CcSEcCtD
Verteporfin—Dry eye—Topiramate—obesity	0.0028	0.0028	CcSEcCtD
Verteporfin—Rash—Phentermine—obesity	0.00277	0.00277	CcSEcCtD
Verteporfin—Dermatitis—Phentermine—obesity	0.00277	0.00277	CcSEcCtD
Verteporfin—Headache—Phentermine—obesity	0.00275	0.00275	CcSEcCtD
Verteporfin—Haemoglobin—Sibutramine—obesity	0.00275	0.00275	CcSEcCtD
Verteporfin—Haemorrhage—Sibutramine—obesity	0.00274	0.00274	CcSEcCtD
Verteporfin—Nausea—Phenylpropanolamine—obesity	0.00273	0.00273	CcSEcCtD
Verteporfin—Hypoaesthesia—Sibutramine—obesity	0.00272	0.00272	CcSEcCtD
Verteporfin—Photosensitivity reaction—Bupropion—obesity	0.00272	0.00272	CcSEcCtD
Verteporfin—Pharyngitis—Sibutramine—obesity	0.00272	0.00272	CcSEcCtD
Verteporfin—Hypersensitivity—Cimetidine—obesity	0.00268	0.00268	CcSEcCtD
Verteporfin—Pneumonia—Bupropion—obesity	0.00267	0.00267	CcSEcCtD
Verteporfin—Visual impairment—Sibutramine—obesity	0.00264	0.00264	CcSEcCtD
Verteporfin—Acute coronary syndrome—Bupropion—obesity	0.00262	0.00262	CcSEcCtD
Verteporfin—Nausea—Phentermine—obesity	0.00261	0.00261	CcSEcCtD
Verteporfin—Asthenia—Cimetidine—obesity	0.00261	0.00261	CcSEcCtD
Verteporfin—Myocardial infarction—Bupropion—obesity	0.0026	0.0026	CcSEcCtD
Verteporfin—Conjunctivitis—Bupropion—obesity	0.00258	0.00258	CcSEcCtD
Verteporfin—Eye disorder—Sibutramine—obesity	0.00256	0.00256	CcSEcCtD
Verteporfin—Immune system disorder—Orlistat—obesity	0.00255	0.00255	CcSEcCtD
Verteporfin—Sweating—Bupropion—obesity	0.00255	0.00255	CcSEcCtD
Verteporfin—Sleep disorder—Topiramate—obesity	0.00254	0.00254	CcSEcCtD
Verteporfin—Dizziness—Diethylpropion—obesity	0.00253	0.00253	CcSEcCtD
Verteporfin—Angiopathy—Sibutramine—obesity	0.00248	0.00248	CcSEcCtD
Verteporfin—Immune system disorder—Sibutramine—obesity	0.00247	0.00247	CcSEcCtD
Verteporfin—Malnutrition—Orlistat—obesity	0.00246	0.00246	CcSEcCtD
Verteporfin—Eczema—Topiramate—obesity	0.00244	0.00244	CcSEcCtD
Verteporfin—Rash—Diethylpropion—obesity	0.00241	0.00241	CcSEcCtD
Verteporfin—Dermatitis—Diethylpropion—obesity	0.00241	0.00241	CcSEcCtD
Verteporfin—Dizziness—Cimetidine—obesity	0.00241	0.00241	CcSEcCtD
Verteporfin—Haemoglobin—Bupropion—obesity	0.0024	0.0024	CcSEcCtD
Verteporfin—Headache—Diethylpropion—obesity	0.0024	0.0024	CcSEcCtD
Verteporfin—Haemorrhage—Bupropion—obesity	0.00239	0.00239	CcSEcCtD
Verteporfin—Malnutrition—Sibutramine—obesity	0.00238	0.00238	CcSEcCtD
Verteporfin—Back pain—Orlistat—obesity	0.00238	0.00238	CcSEcCtD
Verteporfin—Hypoaesthesia—Bupropion—obesity	0.00237	0.00237	CcSEcCtD
Verteporfin—Pharyngitis—Bupropion—obesity	0.00237	0.00237	CcSEcCtD
Verteporfin—Vision blurred—Orlistat—obesity	0.00232	0.00232	CcSEcCtD
Verteporfin—Visual disturbance—Topiramate—obesity	0.00232	0.00232	CcSEcCtD
Verteporfin—Back pain—Sibutramine—obesity	0.0023	0.0023	CcSEcCtD
Verteporfin—Visual impairment—Bupropion—obesity	0.0023	0.0023	CcSEcCtD
Verteporfin—Rash—Cimetidine—obesity	0.00229	0.00229	CcSEcCtD
Verteporfin—Dermatitis—Cimetidine—obesity	0.00229	0.00229	CcSEcCtD
Verteporfin—Ill-defined disorder—Orlistat—obesity	0.00228	0.00228	CcSEcCtD
Verteporfin—Headache—Cimetidine—obesity	0.00228	0.00228	CcSEcCtD
Verteporfin—Nausea—Diethylpropion—obesity	0.00227	0.00227	CcSEcCtD
Verteporfin—Vision blurred—Sibutramine—obesity	0.00224	0.00224	CcSEcCtD
Verteporfin—Eye disorder—Bupropion—obesity	0.00223	0.00223	CcSEcCtD
Verteporfin—Malaise—Orlistat—obesity	0.00222	0.00222	CcSEcCtD
Verteporfin—Cardiac disorder—Bupropion—obesity	0.00221	0.00221	CcSEcCtD
Verteporfin—Flushing—Bupropion—obesity	0.00221	0.00221	CcSEcCtD
Verteporfin—Vertigo—Orlistat—obesity	0.00221	0.00221	CcSEcCtD
Verteporfin—Ill-defined disorder—Sibutramine—obesity	0.00221	0.00221	CcSEcCtD
Verteporfin—Anaemia—Sibutramine—obesity	0.0022	0.0022	CcSEcCtD
Verteporfin—Diplopia—Topiramate—obesity	0.0022	0.0022	CcSEcCtD
Verteporfin—Osteoarthritis—Topiramate—obesity	0.0022	0.0022	CcSEcCtD
Verteporfin—Angiopathy—Bupropion—obesity	0.00216	0.00216	CcSEcCtD
Verteporfin—Nausea—Cimetidine—obesity	0.00216	0.00216	CcSEcCtD
Verteporfin—Immune system disorder—Bupropion—obesity	0.00215	0.00215	CcSEcCtD
Verteporfin—Malaise—Sibutramine—obesity	0.00215	0.00215	CcSEcCtD
Verteporfin—Cough—Orlistat—obesity	0.00215	0.00215	CcSEcCtD
Verteporfin—Vertigo—Sibutramine—obesity	0.00214	0.00214	CcSEcCtD
Verteporfin—Syncope—Sibutramine—obesity	0.00214	0.00214	CcSEcCtD
Verteporfin—Chest pain—Orlistat—obesity	0.0021	0.0021	CcSEcCtD
Verteporfin—Loss of consciousness—Sibutramine—obesity	0.00209	0.00209	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.00208	0.00208	CcSEcCtD
Verteporfin—Cough—Sibutramine—obesity	0.00208	0.00208	CcSEcCtD
Verteporfin—Malnutrition—Bupropion—obesity	0.00208	0.00208	CcSEcCtD
Verteporfin—Discomfort—Orlistat—obesity	0.00207	0.00207	CcSEcCtD
Verteporfin—Blood creatinine increased—Topiramate—obesity	0.00206	0.00206	CcSEcCtD
Verteporfin—Hypertension—Sibutramine—obesity	0.00206	0.00206	CcSEcCtD
Verteporfin—Liver function test abnormal—Topiramate—obesity	0.00203	0.00203	CcSEcCtD
Verteporfin—Arthralgia—Sibutramine—obesity	0.00203	0.00203	CcSEcCtD
Verteporfin—Chest pain—Sibutramine—obesity	0.00203	0.00203	CcSEcCtD
Verteporfin—Oedema—Orlistat—obesity	0.00201	0.00201	CcSEcCtD
Verteporfin—Back pain—Bupropion—obesity	0.00201	0.00201	CcSEcCtD
Verteporfin—Discomfort—Sibutramine—obesity	0.002	0.002	CcSEcCtD
Verteporfin—Nervous system disorder—Orlistat—obesity	0.00197	0.00197	CcSEcCtD
Verteporfin—Vision blurred—Bupropion—obesity	0.00196	0.00196	CcSEcCtD
Verteporfin—Skin disorder—Orlistat—obesity	0.00195	0.00195	CcSEcCtD
Verteporfin—Oedema—Sibutramine—obesity	0.00194	0.00194	CcSEcCtD
Verteporfin—Hyperhidrosis—Orlistat—obesity	0.00194	0.00194	CcSEcCtD
Verteporfin—Muscular weakness—Topiramate—obesity	0.00194	0.00194	CcSEcCtD
Verteporfin—Ill-defined disorder—Bupropion—obesity	0.00193	0.00193	CcSEcCtD
Verteporfin—Anaemia—Bupropion—obesity	0.00192	0.00192	CcSEcCtD
Verteporfin—Shock—Sibutramine—obesity	0.00191	0.00191	CcSEcCtD
Verteporfin—Skin disorder—Sibutramine—obesity	0.00189	0.00189	CcSEcCtD
Verteporfin—Hyperhidrosis—Sibutramine—obesity	0.00188	0.00188	CcSEcCtD
Verteporfin—Malaise—Bupropion—obesity	0.00187	0.00187	CcSEcCtD
Verteporfin—Vertigo—Bupropion—obesity	0.00187	0.00187	CcSEcCtD
Verteporfin—Syncope—Bupropion—obesity	0.00186	0.00186	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Orlistat—obesity	0.00183	0.00183	CcSEcCtD
Verteporfin—Loss of consciousness—Bupropion—obesity	0.00183	0.00183	CcSEcCtD
Verteporfin—Cough—Bupropion—obesity	0.00181	0.00181	CcSEcCtD
Verteporfin—Hypertension—Bupropion—obesity	0.00179	0.00179	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Sibutramine—obesity	0.00177	0.00177	CcSEcCtD
Verteporfin—Chest pain—Bupropion—obesity	0.00177	0.00177	CcSEcCtD
Verteporfin—Arthralgia—Bupropion—obesity	0.00177	0.00177	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.00176	0.00176	CcSEcCtD
Verteporfin—Discomfort—Bupropion—obesity	0.00175	0.00175	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Orlistat—obesity	0.00173	0.00173	CcSEcCtD
Verteporfin—Dyspnoea—Sibutramine—obesity	0.00173	0.00173	CcSEcCtD
Verteporfin—Photosensitivity reaction—Topiramate—obesity	0.00173	0.00173	CcSEcCtD
Verteporfin—Pain—Orlistat—obesity	0.00172	0.00172	CcSEcCtD
Verteporfin—Pneumonia—Topiramate—obesity	0.0017	0.0017	CcSEcCtD
Verteporfin—Oedema—Bupropion—obesity	0.00169	0.00169	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Sibutramine—obesity	0.00168	0.00168	CcSEcCtD
Verteporfin—Shock—Bupropion—obesity	0.00167	0.00167	CcSEcCtD
Verteporfin—Pain—Sibutramine—obesity	0.00166	0.00166	CcSEcCtD
Verteporfin—Constipation—Sibutramine—obesity	0.00166	0.00166	CcSEcCtD
Verteporfin—Nervous system disorder—Bupropion—obesity	0.00166	0.00166	CcSEcCtD
Verteporfin—Feeling abnormal—Orlistat—obesity	0.00166	0.00166	CcSEcCtD
Verteporfin—Skin disorder—Bupropion—obesity	0.00165	0.00165	CcSEcCtD
Verteporfin—Conjunctivitis—Topiramate—obesity	0.00165	0.00165	CcSEcCtD
Verteporfin—Hyperhidrosis—Bupropion—obesity	0.00164	0.00164	CcSEcCtD
Verteporfin—Feeling abnormal—Sibutramine—obesity	0.0016	0.0016	CcSEcCtD
Verteporfin—Urticaria—Orlistat—obesity	0.0016	0.0016	CcSEcCtD
Verteporfin—Body temperature increased—Orlistat—obesity	0.00159	0.00159	CcSEcCtD
Verteporfin—Urticaria—Sibutramine—obesity	0.00154	0.00154	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Bupropion—obesity	0.00154	0.00154	CcSEcCtD
Verteporfin—Body temperature increased—Sibutramine—obesity	0.00154	0.00154	CcSEcCtD
Verteporfin—Haemoglobin—Topiramate—obesity	0.00153	0.00153	CcSEcCtD
Verteporfin—Haemorrhage—Topiramate—obesity	0.00152	0.00152	CcSEcCtD
Verteporfin—Hypoaesthesia—Topiramate—obesity	0.00151	0.00151	CcSEcCtD
Verteporfin—Dyspnoea—Bupropion—obesity	0.00151	0.00151	CcSEcCtD
Verteporfin—Pharyngitis—Topiramate—obesity	0.00151	0.00151	CcSEcCtD
Verteporfin—Hypersensitivity—Orlistat—obesity	0.00148	0.00148	CcSEcCtD
Verteporfin—Visual impairment—Topiramate—obesity	0.00146	0.00146	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Bupropion—obesity	0.00146	0.00146	CcSEcCtD
Verteporfin—Pain—Bupropion—obesity	0.00145	0.00145	CcSEcCtD
Verteporfin—Constipation—Bupropion—obesity	0.00145	0.00145	CcSEcCtD
Verteporfin—Asthenia—Orlistat—obesity	0.00144	0.00144	CcSEcCtD
Verteporfin—Hypersensitivity—Sibutramine—obesity	0.00143	0.00143	CcSEcCtD
Verteporfin—Pruritus—Orlistat—obesity	0.00142	0.00142	CcSEcCtD
Verteporfin—Eye disorder—Topiramate—obesity	0.00142	0.00142	CcSEcCtD
Verteporfin—Flushing—Topiramate—obesity	0.00141	0.00141	CcSEcCtD
Verteporfin—Cardiac disorder—Topiramate—obesity	0.00141	0.00141	CcSEcCtD
Verteporfin—Feeling abnormal—Bupropion—obesity	0.0014	0.0014	CcSEcCtD
Verteporfin—Asthenia—Sibutramine—obesity	0.00139	0.00139	CcSEcCtD
Verteporfin—Angiopathy—Topiramate—obesity	0.00138	0.00138	CcSEcCtD
Verteporfin—Pruritus—Sibutramine—obesity	0.00138	0.00138	CcSEcCtD
Verteporfin—Immune system disorder—Topiramate—obesity	0.00137	0.00137	CcSEcCtD
Verteporfin—Urticaria—Bupropion—obesity	0.00135	0.00135	CcSEcCtD
Verteporfin—Body temperature increased—Bupropion—obesity	0.00134	0.00134	CcSEcCtD
Verteporfin—Dizziness—Orlistat—obesity	0.00133	0.00133	CcSEcCtD
Verteporfin—Malnutrition—Topiramate—obesity	0.00132	0.00132	CcSEcCtD
Verteporfin—Dizziness—Sibutramine—obesity	0.00129	0.00129	CcSEcCtD
Verteporfin—Back pain—Topiramate—obesity	0.00128	0.00128	CcSEcCtD
Verteporfin—Rash—Orlistat—obesity	0.00127	0.00127	CcSEcCtD
Verteporfin—Dermatitis—Orlistat—obesity	0.00127	0.00127	CcSEcCtD
Verteporfin—Headache—Orlistat—obesity	0.00126	0.00126	CcSEcCtD
Verteporfin—Hypersensitivity—Bupropion—obesity	0.00125	0.00125	CcSEcCtD
Verteporfin—Vision blurred—Topiramate—obesity	0.00125	0.00125	CcSEcCtD
Verteporfin—Ill-defined disorder—Topiramate—obesity	0.00123	0.00123	CcSEcCtD
Verteporfin—Rash—Sibutramine—obesity	0.00123	0.00123	CcSEcCtD
Verteporfin—Dermatitis—Sibutramine—obesity	0.00122	0.00122	CcSEcCtD
Verteporfin—Anaemia—Topiramate—obesity	0.00122	0.00122	CcSEcCtD
Verteporfin—Headache—Sibutramine—obesity	0.00122	0.00122	CcSEcCtD
Verteporfin—Asthenia—Bupropion—obesity	0.00122	0.00122	CcSEcCtD
Verteporfin—Pruritus—Bupropion—obesity	0.0012	0.0012	CcSEcCtD
Verteporfin—Nausea—Orlistat—obesity	0.00119	0.00119	CcSEcCtD
Verteporfin—Malaise—Topiramate—obesity	0.00119	0.00119	CcSEcCtD
Verteporfin—Vertigo—Topiramate—obesity	0.00119	0.00119	CcSEcCtD
Verteporfin—Syncope—Topiramate—obesity	0.00119	0.00119	CcSEcCtD
Verteporfin—Loss of consciousness—Topiramate—obesity	0.00116	0.00116	CcSEcCtD
Verteporfin—Nausea—Sibutramine—obesity	0.00115	0.00115	CcSEcCtD
Verteporfin—Cough—Topiramate—obesity	0.00115	0.00115	CcSEcCtD
Verteporfin—Hypertension—Topiramate—obesity	0.00114	0.00114	CcSEcCtD
Verteporfin—Arthralgia—Topiramate—obesity	0.00113	0.00113	CcSEcCtD
Verteporfin—Chest pain—Topiramate—obesity	0.00113	0.00113	CcSEcCtD
Verteporfin—Dizziness—Bupropion—obesity	0.00112	0.00112	CcSEcCtD
Verteporfin—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.00112	0.00112	CcSEcCtD
Verteporfin—Discomfort—Topiramate—obesity	0.00111	0.00111	CcSEcCtD
Verteporfin—Oedema—Topiramate—obesity	0.00108	0.00108	CcSEcCtD
Verteporfin—Rash—Bupropion—obesity	0.00107	0.00107	CcSEcCtD
Verteporfin—Dermatitis—Bupropion—obesity	0.00107	0.00107	CcSEcCtD
Verteporfin—Shock—Topiramate—obesity	0.00106	0.00106	CcSEcCtD
Verteporfin—Headache—Bupropion—obesity	0.00106	0.00106	CcSEcCtD
Verteporfin—Nervous system disorder—Topiramate—obesity	0.00106	0.00106	CcSEcCtD
Verteporfin—Skin disorder—Topiramate—obesity	0.00105	0.00105	CcSEcCtD
Verteporfin—Hyperhidrosis—Topiramate—obesity	0.00104	0.00104	CcSEcCtD
Verteporfin—Nausea—Bupropion—obesity	0.00101	0.00101	CcSEcCtD
Verteporfin—Musculoskeletal discomfort—Topiramate—obesity	0.000984	0.000984	CcSEcCtD
Verteporfin—Dyspnoea—Topiramate—obesity	0.000963	0.000963	CcSEcCtD
Verteporfin—Gastrointestinal disorder—Topiramate—obesity	0.000932	0.000932	CcSEcCtD
Verteporfin—Pain—Topiramate—obesity	0.000923	0.000923	CcSEcCtD
Verteporfin—Constipation—Topiramate—obesity	0.000923	0.000923	CcSEcCtD
Verteporfin—Feeling abnormal—Topiramate—obesity	0.00089	0.00089	CcSEcCtD
Verteporfin—Urticaria—Topiramate—obesity	0.000858	0.000858	CcSEcCtD
Verteporfin—Body temperature increased—Topiramate—obesity	0.000854	0.000854	CcSEcCtD
Verteporfin—Hypersensitivity—Topiramate—obesity	0.000795	0.000795	CcSEcCtD
Verteporfin—Asthenia—Topiramate—obesity	0.000775	0.000775	CcSEcCtD
Verteporfin—Pruritus—Topiramate—obesity	0.000764	0.000764	CcSEcCtD
Verteporfin—Dizziness—Topiramate—obesity	0.000714	0.000714	CcSEcCtD
Verteporfin—Rash—Topiramate—obesity	0.000681	0.000681	CcSEcCtD
Verteporfin—Dermatitis—Topiramate—obesity	0.00068	0.00068	CcSEcCtD
Verteporfin—Headache—Topiramate—obesity	0.000676	0.000676	CcSEcCtD
Verteporfin—Nausea—Topiramate—obesity	0.000641	0.000641	CcSEcCtD
